Skip Navigation
Genetics Home Reference: your guide to understanding genetic conditions     A service of the U.S. National Library of Medicine®


Reviewed May 2013

What is the official name of the SMARCB1 gene?

The official name of this gene is “SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1.”

SMARCB1 is the gene's official symbol. The SMARCB1 gene is also known by other names, listed below.

What is the normal function of the SMARCB1 gene?

The SMARCB1 gene provides instructions for making a protein that forms one piece (subunit) of several different SWI/SNF protein complexes. SWI/SNF complexes regulate gene activity (expression) by a process known as chromatin remodeling. Chromatin is the network of DNA and protein that packages DNA into chromosomes. The structure of chromatin can be changed (remodeled) to alter how tightly DNA is packaged. Chromatin remodeling is one way gene expression is regulated during development; when DNA is tightly packed, gene expression is lower than when DNA is loosely packed.

Through their ability to regulate gene activity, SWI/SNF complexes are involved in many processes, including repairing damaged DNA; copying (replicating) DNA; and controlling the growth, division, and maturation (differentiation) of cells. The SMARCB1 protein and other SWI/SNF subunits are thought to act as tumor suppressors, which keep cells from growing and dividing too rapidly or in an uncontrolled way.

The role of the SMARCB1 protein within the SWI/SNF complex is not completely understood.

How are changes in the SMARCB1 gene related to health conditions?

Coffin-Siris syndrome - caused by mutations in the SMARCB1 gene

At least two mutations in the SMARCB1 gene can cause Coffin-Siris syndrome. This condition is characterized by delayed development, abnormalities of the fifth (pinky) fingers or toes, and characteristic facial features that are described as coarse. These SMARCB1 gene mutations change or remove single protein building blocks (amino acids) in the SMARCB1 protein. Although it is unclear how these changes affect SWI/SNF complexes, researchers suggest that SMARCB1 gene mutations result in abnormal chromatin remodeling. Disturbance of this process alters the activity of many genes and disrupts several cellular processes, which could explain the diverse signs and symptoms of Coffin-Siris syndrome. People with Coffin-Siris syndrome do not appear to have an increased risk of cancer (see below).

other disorders - caused by mutations in the SMARCB1 gene

Mutations in the SMARCB1 gene cause rhabdoid tumor predisposition syndrome (RTPS). Individuals with this condition have an increased risk of developing aggressive cancerous growths called rhabdoid tumors, which form in the brain (often called atypical teratoid/rhabdoid tumors) and in the kidney (often called malignant rhabdoid tumors). These tumors usually occur in infants and young children. Some children with RTPS also develop schwannomas, which are noncancerous (benign) tumors of the nerve cells. RTPS is caused by a single inherited mutation in the SMARCB1 gene that is present in cells throughout the body. An additional mutation that deletes the normal copy of the gene is needed for tumors to develop. This second mutation, called a somatic mutation, is acquired during a person's lifetime and is present only in tumor cells. In combination, the inherited and somatic mutations lead to the absence of SMARCB1 protein.

Somatic mutations in the SMARCB1 gene that result in the absence of SMARCB1 protein cause noninherited (sporadic) rhabdoid tumors in children. The mechanism by which inherited or somatic SMARCB1 gene mutations lead to rhabdoid tumors is unknown.

Inherited SMARCB1 gene mutations can also cause schwannomatosis, which is characterized by the development of multiple schwannomas. In contrast to gene mutations that cause rhabdoid tumors, these mutations are thought to lead to production of an altered SMARCB1 protein that likely has some function. However, it is unclear how the altered protein leads to development of schwannomas. It is likely that other genetic changes in addition to SMARCB1 gene mutations are necessary for schwannoma development.

Where is the SMARCB1 gene located?

Cytogenetic Location: 22q11.23

Molecular Location on chromosome 22: base pairs 23,786,963 to 23,834,518

(Homo sapiens Annotation Release 107, GRCh38.p2) (NCBI (

The SMARCB1 gene is located on the long (q) arm of chromosome 22 at position 11.23.

The SMARCB1 gene is located on the long (q) arm of chromosome 22 at position 11.23.

More precisely, the SMARCB1 gene is located from base pair 23,786,963 to base pair 23,834,518 on chromosome 22.

See How do geneticists indicate the location of a gene? ( in the Handbook.

Where can I find additional information about SMARCB1?

You and your healthcare professional may find the following resources about SMARCB1 helpful.

You may also be interested in these resources, which are designed for genetics professionals and researchers.

What other names do people use for the SMARCB1 gene or gene products?

  • BAF47
  • BRG1-associated factor 47
  • hSNF5
  • hSNFS
  • INI1
  • integrase interactor 1 protein
  • MRD15
  • PPP1R144
  • RDT
  • RTPS1
  • Sfh1p
  • SNF5
  • SNF5 homolog
  • SNF5L1
  • Snr1
  • sucrose nonfermenting, yeast, homolog-like 1
  • SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1

See How are genetic conditions and genes named? ( in the Handbook.

What glossary definitions help with understanding SMARCB1?

acids ; actin ; atypical ; benign ; cancer ; chromatin ; chromatin remodeling ; differentiation ; DNA ; gene ; gene expression ; inherited ; kidney ; mutation ; predisposition ; protein ; schwannoma ; somatic mutation ; sporadic ; subunit ; syndrome ; tumor

You may find definitions for these and many other terms in the Genetics Home Reference Glossary.


  • Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res. 2002 Nov;8(11):3461-7. (
  • Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011 Jan;56(1):7-15. doi: 10.1002/pbc.22831. (
  • NCBI Gene (
  • Santen GW, Kriek M, van Attikum H. SWI/SNF complex in disorder: SWItching from malignancies to intellectual disability. Epigenetics. 2012 Nov;7(11):1219-24. doi: 10.4161/epi.22299. Epub 2012 Sep 25. Review. (
  • Smith MJ, Walker JA, Shen Y, Stemmer-Rachamimov A, Gusella JF, Plotkin SR. Expression of SMARCB1 (INI1) mutations in familial schwannomatosis. Hum Mol Genet. 2012 Dec 15;21(24):5239-45. doi: 10.1093/hmg/dds370. Epub 2012 Sep 4. (
  • Tsurusaki Y, Okamoto N, Ohashi H, Kosho T, Imai Y, Hibi-Ko Y, Kaname T, Naritomi K, Kawame H, Wakui K, Fukushima Y, Homma T, Kato M, Hiraki Y, Yamagata T, Yano S, Mizuno S, Sakazume S, Ishii T, Nagai T, Shiina M, Ogata K, Ohta T, Niikawa N, Miyatake S, Okada I, Mizuguchi T, Doi H, Saitsu H, Miyake N, Matsumoto N. Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat Genet. 2012 Mar 18;44(4):376-8. doi: 10.1038/ng.2219. (
  • Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011 Jun 9;11(7):481-92. doi: 10.1038/nrc3068. Review. (


The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? ( in the Handbook.

Reviewed: May 2013
Published: February 8, 2016